Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

Saman Hewamana, MRCP, MRCPath, Mathew Clement, BSc, Thet Thet Lin, PhD, Chris Jenkins, MRCP, Chris Fegan, FRCP,FRCPath,MD, Clare Rowntree, FRCP,MRCPath,PhD, Paul Brennan, PhD, Chris Pepper, PhD

Blood (2007) 110 (11): 3091.

https://doi.org/10.1182/blood.V110.11.3091.3091

Published: 2007

Journal Articles

CD21 Expression Is Inversely Correlated with the Ability of CLL Cells To Induce Tyrosine Phosphorylation in Response to Anti-IgM.

Chris Pepper, PhD, Suhair Alghazal, MD, Paul Brennan, PhD, Clare Rowntree, MB, PhD, Thet Thet Lin, PhD, Guy Pratt, MD, Chris Fegan, MD

Blood (2006) 108 (11): 2806.

https://doi.org/10.1182/blood.V108.11.2806.2806

Published: 2006

Journal Articles

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Patrick Hayden, MD, Prerna Tewari, PhD, Anthony Staines, MD, Derek Morris, PhD, Dominique Crowley, MD, Alexandra Nieters, PhD, Nicholas Becker, MD, Silvia de Sanjose, MD, L. Foretova, MD, Mark Maynardie, MD, Pier Luigi Coco, MD, Paolo Boefetta, PhD, Paul Brennan, PhD, Paul V. Browne, MD, Mark Lawler, PhD

Blood (2006) 108 (11): 3416.

https://doi.org/10.1182/blood.V108.11.3416.3416

Published: 2006

Journal Articles

Integrating Prognostic Markers and Cellular Signaling Identifies More Chronic Lymphocytic Leukemia Patients with Adverse Prognosis.

Paul Brennan, PhD, Suhair Alghazal, MD, Naomi Price Lloyd, PhD, Janet E. Williams, PhD, Jeff D. Griffiths, PhD, Clare Rowntree, MB, PhD, Guy Pratt, MD, Chris Fegan, MD, Chris Pepper, PhD

Blood (2006) 108 (11): 2782.

https://doi.org/10.1182/blood.V108.11.2782.2782

Published: 2006

Journal Articles

Constitutive Nuclear p65 NF-kB Expression Predicts for Spontaneous Apoptosis and In Vitro Sensitivity to Fludarabine in CLL Cells.

Saman Hewamana, MB, Clare Rowntree, MB, PhD, Thet Thet Lin, PhD, Chris Pepper, PhD, Paul Brennan, PhD, Chris Fegan, MD

Blood (2006) 108 (11): 4974.

https://doi.org/10.1182/blood.V108.11.4974.4974

Published: 2006

Journal Articles

ZAP-70 Expression Is More Predictive Than V H Gene Mutational Status of BCR-Mediated Tyrosine Phosphorylation, NF-κB Activation and CLL Cell Survival.

Chris Pepper, PhD, Suhair Alghazal, MD, Paul Brennan, PhD, Clare Rowntree, MD, PhD, Guy Pratt, MD, Chris Fegan, MD

Blood (2005) 106 (11): 2942.

https://doi.org/10.1182/blood.V106.11.2942.2942

Published: 2005

Journal Articles

The Novel Anti-Leukemic Agent LC-1, Is Preferentially Cytotoxic in CLL Cells Derived from Poor Prognostic Subsets.

Chris Pepper, PhD, Chris Fegan, MD, Paul Brennan, PhD, Ken Mills, PhD, Alan K. Burnett, MD

Blood (2005) 106 (11): 2981.

https://doi.org/10.1182/blood.V106.11.2981.2981

Published: 2005

NARROW

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

CD21 Expression Is Inversely Correlated with the Ability of CLL Cells To Induce Tyrosine Phosphorylation in Response to Anti-IgM.

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Integrating Prognostic Markers and Cellular Signaling Identifies More Chronic Lymphocytic Leukemia Patients with Adverse Prognosis.

Constitutive Nuclear p65 NF-kB Expression Predicts for Spontaneous Apoptosis and In Vitro Sensitivity to Fludarabine in CLL Cells.

ZAP-70 Expression Is More Predictive Than V H Gene Mutational Status of BCR-Mediated Tyrosine Phosphorylation, NF-κB Activation and CLL Cell Survival.

The Novel Anti-Leukemic Agent LC-1, Is Preferentially Cytotoxic in CLL Cells Derived from Poor Prognostic Subsets.

Email alerts

ASH Publications

American Society of Hematology

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

CD21 Expression Is Inversely Correlated with the Ability of CLL Cells To Induce Tyrosine Phosphorylation in Response to Anti-IgM.

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Integrating Prognostic Markers and Cellular Signaling Identifies More Chronic Lymphocytic Leukemia Patients with Adverse Prognosis.

Constitutive Nuclear p65 NF-kB Expression Predicts for Spontaneous Apoptosis and In Vitro Sensitivity to Fludarabine in CLL Cells.

ZAP-70 Expression Is More Predictive Than V H Gene Mutational Status of BCR-Mediated Tyrosine Phosphorylation, NF-κB Activation and CLL Cell Survival.

The Novel Anti-Leukemic Agent LC-1, Is Preferentially Cytotoxic in CLL Cells Derived from Poor Prognostic Subsets.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only